The findings "are in agreement with American Diabetes Association Standards of Care, and recent international consensus recommending CGM and AID for most people with type 1 diabetes, and early initiation of diabetes technology from the onset of type 1 diabetes," write Kagan E. Karakus, MD, of the Barbara Davis Center, and colleagues in the article, which was published online in Diabetes Care.